TrialCancer chemotherapy and pharmacology2013
A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancer.
Dana E Rathkopf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
50 papers cite it
this paperpooled ittrialcites it